Re: Zenith Materials From Investor Village

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Rank: President [?]

Points: 4445 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Materials From Investor Village

in response to

Zenith Materials From Investor Village

SanFrancisco99

posted on Nov 10, 2017 02:01PM

SanFran, good re post.

As I recall you were involved in patents in IT back in the 1990s or did I get it wrong?

If so, do you have a POV on what complexity might imply about value and the extent of protection. Might it be significant in terms of blocking out BPs or other biotechs?